What is the Org number of STIFTELSEN NORDTUN HELSEREHAB?

STIFTELSEN NORDTUN HELSEREHAB is registered with Brønnøysundsregistrene under Org 936079857.

What is the revenue of STIFTELSEN NORDTUN HELSEREHAB?

STIFTELSEN NORDTUN HELSEREHAB reported revenue of NOK 54,5M in 2024.

STIFTELSEN NORDTUN HELSEREHAB employs 66 people as of the latest annual report.

Mona Alm is Chief Executive Officer of STIFTELSEN NORDTUN HELSEREHAB, in role since 2025.

Per-Steinar Krogstad chairs the board of STIFTELSEN NORDTUN HELSEREHAB, in role since 2024.

STIFTELSEN NORDTUN HELSEREHAB's registered address is Nordtunveien 15, 8170 Engavågen.

STIActive

Org 936079857Nordtunveien 15, 8170 EngavågenResidential nursing care activities · NACE 8710Est. 199566 employees

Actively employed in the business

Name	Role	Member since
Current (4)
MA Mona Alm Chief Executive Officer	Chief Executive Officer	2025
MK Merete Karin Kristensen Deputy Member	Deputy Member	2024
BG Bjørg Gustavsen Deputy Member	Deputy Member	2025
LJ Line Jæger Hansen Deputy Member	Deputy Member	2025
Former (3)
MM Mona Mork Chief Executive Officer	Chief Executive Officer	2025 – 2025
TD Trond Dragland Chief Executive Officer	Chief Executive Officer	2024 – 2025
SN Sissel Norum Chief Executive Officer	Chief Executive Officer	2024 – 2024

Non-executive oversight

Name	Role	Member since
Current (5)
PK Per-Steinar Krogstad	Chairman	2024
TK Tore Krogstad	Board of Directors	2024
ØS Øystein Samnøen	Board of Directors	2025
TS Thomas Sæle	Board of Directors	2021
MP May-Britt Pedersen Delbekk	Deputy Chairman	2025
Former (7)
AO Aksel Owe Olsen	Board of Directors	2020 – 2021
IS Inger Stokstad	Chairman	2020 – 2021
JM Jan Martin Sahl	Board of Directors	2020 – 2021
AE Aud Eline Angell	Chairman	2021 – 2024
TR Tormod Reidar Myrvang	Board of Directors	2020 – 2021
MF Margaret Frøseth Li	Deputy Chairman	2021 – 2024
KO Knut Osnes	Board of Directors	2021 – 2024

As of last annual report

No shareholder data available.

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.